Physician profile
Thomas L Ewing
NPI 1730188533
$2,216.28
in general payments reported to CMS, 2019-2025
20 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $127 · 2021: $187 · 2022: $352 · 2023: $642 · 2024: $151 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $537.18 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Antares Pharma, INC. | $205.47 | 2020-2024 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $184.66 | 2021-2024 | Axonics |
| Kerecis Limited | $171.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pfizer INC. | $157.95 | 2022-2023 | |
| Boston Scientific Corporation | $131.75 | 2021-2025 | Ams 700, Axonics |
| Cook Medical LLC | $128.15 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $118.51 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $101.11 | 2023-2025 | Jelmyto |
| Coloplast Corp | $89.37 | 2023 | Titan |
| Richard Wolf Medical Instruments Corp. | $74.24 | 2021 | |
| Halozyme INC | $68.50 | 2023 | |
| Janssen Biotech, INC. | $50.77 | 2025 | Erleada, Akeega |
| Abc Home Medical Supply, INC. | $50.71 | 2023-2024 | |
| Hollister Incorporated | $39.53 | 2023-2024 | Infyna Chic |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $34.91 | 2023 | Pylarify |
| Myovant Sciences INC. | $23.37 | 2022 | |
| Civco Medical Instruments | $18.26 | 2024 | |
| Dendreon Pharmaceuticals LLC | $15.73 | 2025 | Provenge |
| Urovant Sciences INC | $14.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.